POURGHASEMI‐LATI ET AL.
3 of 11
Then the catalyst was separated using an external mag-
net. The solvent (ethanol) was evaporated to afford the
pure product. If needed, for further purification, the prod-
uct can be recrystallized from ethanol.
2.4.5 | Ethyl‐7‐amino‐5‐(4‐chlorophenyl)‐
2,4‐dioxo‐1,3,4,5‐tetrahydro‐2H‐pyrano[2,3‐
d]pyrimidine‐6‐carboxylate (5n)
FT‐IR (KBr, νmax, cm−1): 3311, 3188, 3091, 2228, 1899,
1
1648, 1543. H NMR (400 MHz, DMSO, δ, ppm): 2.17
(3H, s, CH3), 4.8 (2H, s, CH2), 5.28 (s, 1H, H‐5) 4.11
(2H, s, CH2), 2.29 (3H, s, CH3), 7.28 (m, H─ Ar), 7.38
(m, 2H, H─ Ar), 7.75 (s, 2H, NH2), 10.99 (s, 1H, NH),
11.55 (s, 1H, NH). 13C NMR (CDCl3, δ, ppm): 88.3, 98.5,
114.8, 126.9, 128.8, 129.0, 129.9, 130.5, 135.9, 150.1,
155.4, 155.8, 159.7, 160.9. MS: (M+) m/z, 313, 278, 188,
153, 111, 77, 57, 43.
2.4 | Spectroscopic Data
2.4.1 | 5(4‐Cl‐Benzylidene) barbituric acid
(4b)
FT‐IR (KBr, νmax, cm−1): 3404, 3214, 2970, 1755, 1703,
1
1570. H NMR (DMSO, δ, ppm): 7.53 (d, 2H, Ar─ H),
8.08 (2d, 2H, Ar─ H), 8.25 (s, 1H, HC═ C), 11.25 (s, H,
NH), 11.40 (s, 1H, NH). 13C NMR (CDCl3, δ, ppm):
117.46, 127.76, 128.29, 133.25, 133.50, 148.70, 150.16,
165.10. EI‐MS: m/z (%) 250 (M+).
2.4.6 | Ethyl‐7‐amino‐5‐(4‐
methoxyphenyl)‐2,4‐dioxo‐1,3,4,5‐
tetrahydro‐2H‐pyrano[2,3‐d]pyrimidine‐6‐
carboxylate (5p)
FT‐IR (KBr, νmax, cm−1): 3413, 3278, 2239, 2165, 1878,
1662, 1543. 1H NMR (400 MHz, DMSO‐d6, δ, ppm):
3.32 (s, 3H, OCH3), 4.41 (1H, s, H‐5), 3.71 (s, 2H, CH2),
2.49 (s, 3H, CH3) 6.93 (m, 2H, H─ Ar), 7.65 (m, 2H,
H─ Ar), 9.07 (2H, br, s, NH2), 11.09–10.03 (s, br, 2H,
NH). 13C NMR (100 MHz, DMSO‐d6, δ, ppm): 33.03,
37.2, 55.8, 75.6, 114.2, 130.1, 134.1, 143.9, 150.5, 157.2,
162.4, 167.3. EI‐MS: (m/z) = 89 (M+), 269, 232, 221,
201, 176, 149, 110.
2.4.2 | 5(2‐Cl‐Benzylidene) barbituric acid
(4c)
FT‐IR (KBr, νmax, cm−1): 3460, 3120, 2981, 1754, 1569,
1
1454, 1079, 910, 782. HNMR (CDCl3, δ, ppm): 7.36 (t,
1H, H─ Ar), 7.47 (t, 1H, H─ Ar), 7.53 (d, 1H, H─ Ar),
7.73 (d, 1H, Ar─ H), 8.29 (s, 1H, HC═ C), 11.25 (s, 1H,
NH), 11.47 (s, 1H, NH). 13C NMR (CDCl3, δ, ppm):
121.76, 126.29, 128.29, 131.88, 132.25, 133.15, 146.70,
150.16, 160.85, 162.60. EI‐MS: m/z (%) 250 (M+).
3 | RESULTS AND DISCUSSION
2.4.3 | 5(4‐OH‐Benzylidene) barbituric
In recent years, the introduction of new catalysts for the
promotion of organic reactions has become an important
part of our ongoing research programme.[37–39] Based on
the above mentioned difficulties in the preparation of 5‐
arylidine barbituric acids and pyrano[2,3‐d] pyrimidine
derivatives and in continuation of our ongoing research
programme on the introduction of new nanocatalysts
for the promotion of organic reactions, we were inter-
ested in preparing, characterizing and studying the appli-
cability of Fe3O4@SiO2‐Sultone in the synthesis of these
compounds. After preparation of the reagent as described
in Section 2, it was characterized using various methods,
and the obtained results are summarized in the following
sections.
acid (4 h)
FT‐IR (KBr, νmax, cm−1): 3420, 3214, 2970, 1755, 1703,
1
1570. H NMR (DMSO, δ, ppm): 6.86 (d, 2H, Ar─ H),
8.32 (2d, 2H, Ar─ H), 8.24 (s, 1H, HC═ C), 10.68 (S, 1H,
OH), 11.13 (s, H, NH), 11.25 (S, 1H, NH). 13C NMR
(CDCl3, δ, ppm): 115.60, 118.76, 128.70, 148.80, 150.20,
157.65, 165.10. EI‐MS: m/z (%) 232 (M+).
2.4.4 | 7‐Amino‐5‐(4‐methoxyphenyl)‐2,4‐
dioxo‐1,3,4,5‐tetrahydro‐2H‐pyrano[2,3‐d]
pyrimidine‐6‐carbonitrile (5i)
FT‐IR (KBr, νmax, cm−1): 3317, 3282, 3145, 3063, 2215,
1743, 1668. 1H NMR (DMSO, δ, ppm): 10.98 (s, 1H,
NH), 10.80 (s, 1H, NH), 7.14 (d, J = 7.5 Hz, 2H, Ar═
H), 6.86–6.82 (m, 4H, Ar═ H and NH2), 4.16 (s, 1H,
CH), 3.81 (s, 3H, OCH3). 13C NMR (DMSO, δ, ppm):
161.99, 159.11, 155.61, 151.97, 151.36, 130.34, 129.50,
123.56, 113.14, 93.41, 58.66, 57.46, 53.46. MS (m/z) (%):
313.01 (M+).
3.1 | Characterization of Fe3O4@SiO2‐
Sultone
3.1.1 | FT‐IR analysis
FT‐IR spectra of Fe3O4, Fe3O4@SiO2 and Fe3O4@SiO2‐
Sultone are compared in Figure 1. These spectra showed